Literature DB >> 19554414

Supraclavicular failure after breast-conserving therapy in patients with four or more positive axillary lymph nodes when prophylactic supraclavicular irradiation is omitted.

Yasushi Hamamoto1, Masaaki Kataoka, Takatoshi Semba, Kotaro Uwatsu, Yoshifumi Sugawara, Takeshi Inoue, Shinya Sakai, Shoji Aono, Tadaaki Takahashi, Shogo Oda.   

Abstract

PURPOSE: The incidence of supraclavicular metastasis as the initial failure and the failure patterns in patients with four or more positive axillary lymph nodes (PALNs) after breast-conserving therapy (BCT) without prophylactic supraclavicular irradiation were investigated.
MATERIALS AND METHODS: Between 1991 and 2002, a total of 48 women with four or more PALNs underwent BCT without prophylactic supraclavicular irradiation (33 patients with 4-9 PALNs; 15 patients with > or =10 PALNs).
RESULTS: The median follow-up time was 50 months. Among the patients with 4-9 PALNs, 3% had isolated supraclavicular metastasis as the initial failure, and 30% had distant metastasis as the initial failure. Among patients with > or =10 PALNs, 7% had isolated supraclavicular metastasis as the initial failure, and 40% had distant metastasis as the initial failure. The 4-year isolated supraclavicular failure rates were 5% for all patients, 3% for patients with 4-9 PALNs, and 8% for patients with >/=10 PALNs.
CONCLUSION: In patients who had undergone BCT and had had four or more PALNs, the major failure pattern was distant failure with or without locoregional failure; isolated supraclavicular failure as the initial failure comprised a less common failure pattern. Omission of prophylactic supraclavicular irradiation may be acceptable for this subset of patients.

Entities:  

Mesh:

Year:  2009        PMID: 19554414     DOI: 10.1007/s11604-009-0325-4

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  16 in total

1.  Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology.

Authors:  A Recht; S B Edge; L J Solin; D S Robinson; A Estabrook; R E Fine; G F Fleming; S Formenti; C Hudis; J J Kirshner; D A Krause; R R Kuske; A S Langer; G W Sledge; T J Whelan; D G Pfister
Journal:  J Clin Oncol       Date:  2001-03-01       Impact factor: 44.544

2.  Axillary recurrence following conservative surgery and radiotherapy in early breast cancer.

Authors:  J E Livsey; B Magee; A L Stewart; R Swindell
Journal:  Clin Oncol (R Coll Radiol)       Date:  2000       Impact factor: 4.126

3.  Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer.

Authors:  J Ragaz; S M Jackson; N Le; I H Plenderleith; J J Spinelli; V E Basco; K S Wilson; M A Knowling; C M Coppin; M Paradis; A J Coldman; I A Olivotto
Journal:  N Engl J Med       Date:  1997-10-02       Impact factor: 91.245

4.  Supraclavicular nodal failure in patients with one to three positive axillary lymph nodes treated with breast conserving surgery and breast irradiation, without supraclavicular node radiation.

Authors:  Shruthi G Reddy; Krystyna D Kiel
Journal:  Breast J       Date:  2007 Jan-Feb       Impact factor: 2.431

5.  Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

Authors:  M Overgaard; M B Jensen; J Overgaard; P S Hansen; C Rose; M Andersson; C Kamby; M Kjaer; C C Gadeberg; B B Rasmussen; M Blichert-Toft; H T Mouridsen
Journal:  Lancet       Date:  1999-05-15       Impact factor: 79.321

6.  Prospective multicenter study of combined treatment with chemotherapy and radiotherapy in breast cancer women with the rare clinical scenario of ipsilateral supraclavicular node recurrence without distant metastases.

Authors:  Stefano Pergolizzi; Vincenzo Adamo; Elvio Russi; Anna Santacaterina; Roberto Maisano; Gianmauro Numico; Carmela Palazzolo; Francesco Ferraù; Nicola Settineri; Giuseppe Altavilla; Andrea Girlando; Pietro Spadaro; Stefano Cascinu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-01-30       Impact factor: 7.038

7.  Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.

Authors:  M Overgaard; P S Hansen; J Overgaard; C Rose; M Andersson; F Bach; M Kjaer; C C Gadeberg; H T Mouridsen; M B Jensen; K Zedeler
Journal:  N Engl J Med       Date:  1997-10-02       Impact factor: 91.245

8.  The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy.

Authors:  F A Vicini; E M Horwitz; M D Lacerna; D M Brown; J White; C F Dmuchowski; V R Kini; A Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-12-01       Impact factor: 7.038

9.  Incidence and time of occurrence of regional recurrence in stage I-II breast cancer: value of adjuvant irradiation.

Authors:  J Fodor; J Toth; T Major; C Polgar; G Nemeth
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-05-01       Impact factor: 7.038

10.  Should adjuvant radiotherapy to the supraclavicular fossa be routinely given in patients with breast conservative treatment?

Authors:  Chun-Wei Wang; Wen-Hong Kuo; King-Jen Chang; Chiun-Sheng Huang; Jason Chia-Hsien Cheng
Journal:  J Surg Oncol       Date:  2007-08-01       Impact factor: 3.454

View more
  1 in total

1.  Treatment and prognosis for retrograde cervical lymph node metastases in breast cancer.

Authors:  Rong Qin; Qiaoyu Zhang; Jianfeng Weng; Weiping Liu; Bo Zhang; Gang Lv; Yi Wang; Youjun Wu; Yongdong Pu
Journal:  Contemp Oncol (Pozn)       Date:  2015-05-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.